Agranulocytosis and Systemic candida

Summary:

Systemic candida is found among people with Agranulocytosis, especially for people who are female, 50-59 old.

The study analyzes which people have Systemic candida with Agranulocytosis. It is created by eHealthMe based on reports of 18 people who have Agranulocytosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Agranulocytosis?

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection) is found to be associated with 2,325 drugs and 3,596 conditions by eHealthMe. Check the latest studies of Agranulocytosis.

What is Systemic candida?

Systemic candida (whole body fungal infection) is found to be associated with 279 drugs and 410 conditions by eHealthMe. Check the latest studies of Systemic candida.

On Aug, 13, 2026

18 people who have Agranulocytosis and Systemic Candida are studied.

Would you have Systemic candida when you have Agranulocytosis?

Gender of people who have Agranulocytosis and experienced Systemic Candida *:

female: 53.85 %
male: 46.15 %

Age of people who have Agranulocytosis and experienced Systemic Candida *:

Common co-existing conditions for these people *:

Pain: 5 people, 27.78%
Hyperglycemia (high blood sugar): 3 people, 16.67%
High Blood Pressure: 3 people, 16.67%
Inflammation: 3 people, 16.67%
Pneumonia: 3 people, 16.67%
Oedema (fluid collection in tissue): 2 people, 11.11%
Fever: 2 people, 11.11%
Thymoma (a tumour originating from the epithelial cells of the thymus): 2 people, 11.11%
Epstein-Barr Virus Associated Lymphoma (epstein-barr virus associated tumour): 2 people, 11.11%
Menopause (end of monthly cycles in women): 2 people, 11.11%

Common drugs taken by these people *:

Cytarabine: 6 people, 33.33%
Pantoprazole: 4 people, 22.22%
Fungizone: 4 people, 22.22%
Decitabine: 4 people, 22.22%
Oxycodone: 4 people, 22.22%
Fludarabine Phosphate: 4 people, 22.22%
Valacyclovir Hydrochloride: 3 people, 16.67%
Sulfamethoxazole And Trimethoprim: 3 people, 16.67%
Methotrexate: 3 people, 16.67%
Vancomycin: 3 people, 16.67%

Common symptoms for these people *:

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 27.78%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 5 people, 27.78%
Malignant Neoplasm Progression (cancer tumour came back): 4 people, 22.22%
Anaemia (lack of blood): 4 people, 22.22%
Drug Ineffective: 3 people, 16.67%
Diabetes Insipidus (diabetes caused by a deficiency of the pituitary hormone vasopressin, which regulates kidney function): 3 people, 16.67%
Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 3 people, 16.67%
Stomatitis (inflammation of mucous membrane of mouth): 2 people, 11.11%
Serratia Infection (bacterial infection): 2 people, 11.11%
Herpes Zoster: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Systemic candida?

- Check whether Systemic candida is associated with a drug or a condition

Related publications that referenced our studies

Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .
Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .

Related studies:

Treatments, associated drugs and conditions:

Agranulocytosis (213,267 reports)
Systemic candida (3,812 reports)

All the drugs that are associated with Systemic candida:

Systemic candida (279 drugs)

All the conditions that are associated with Systemic candida:

Systemic candida (410 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Systemic candida and Agranulocytosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.